Authors:
KUDELKA AP
LEVY T
VERSCHRAEGEN CF
EDWARDS CL
PIAMSOMBOON S
TERMRUNGRUANGLERT W
FREEDMAN RS
KAPLAN AL
KIEBACK DG
MEYERS CA
JAECKLE KA
LOYER E
STEGER M
MANTE R
MAVLIGIT G
KILLIAN A
TANG RA
GUTTERMAN JU
KAVANAGH JJ
Citation: Ap. Kudelka et al., A PHASE-I STUDY OF TNP-470 ADMINISTERED TO PATIENTS WITH ADVANCED SQUAMOUS-CELL CANCER OF THE CERVIX, Clinical cancer research, 3(9), 1997, pp. 1501-1505
Authors:
HOLMES FA
LOPEZ A
MAVLIGIT G
FRASCHINI G
FRYE D
HORTOBAGYI GN
Citation: Fa. Holmes et al., SECONDARY DRUG-RESISTANCE IN BREAST-CANCER - FAILURE TO REVERSE WITH ORAL NIFEDIPINE, International journal of cancer, 73(2), 1997, pp. 184-186
Authors:
BEDIKIAN AY
LEGHA SS
MAVLIGIT G
CARRASCO CH
KHORANA S
PLAGER C
PAPADOPOULOS N
BENJAMIN RS
Citation: Ay. Bedikian et al., TREATMENT OF UVEAL MELANOMA METASTATIC TO THE LIVER - A REVIEW OF THEM-D-ANDERSON-CANCER-CENTER EXPERIENCE AND PROGNOSTIC FACTORS, Cancer, 76(9), 1995, pp. 1665-1670
Authors:
ESTROV Z
TALPAZ M
MAVLIGIT G
PAZDUR R
HARRIS D
GREENBERG SM
KURZROCK R
Citation: Z. Estrov et al., ELEVATED PLASMA THROMBOPOIETIC ACTIVITY IN PATIENTS WITH METASTATIC CANCER-RELATED THROMBOCYTOSIS, The American journal of medicine, 98(6), 1995, pp. 551-558